EHI
GRAL

Eagle Health Investments’s GRAIL Inc GRAL Stock Holding History

Eagle Health Investments’s Portfolio GRAL Stock Details GRAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,124
Closed -$948K – 22
2024
Q4 		$948K Hold
53,124
– – 0.23% 18
2024
Q3 		$731K Hold
53,124
– – 0.14% 25
2024
Q2 		$817K Buy
+53,124
New +$862K 0.14% 26

Other funds holding GRAL

CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

Eagle Health Investments's GRAL Position: Q1 2025 in Review

Eagle Health Investments sold out of GRAIL Inc (GRAL) in Q1 2025, closing a stake of 53,124 shares — an estimated $948K sold.

Eagle Health Investments first reported a position in GRAL in Q2 2024 and held it in 3 quarters. The position peaked at $948K in Q4 2024. 313 funds tracked by Wall St. Rank hold GRAL as of Q1 2025.

  • Eagle Health Investments reported no remaining GRAIL Inc position as of Q1 2025 after selling out during the quarter.
  • Eagle Health Investments sold 53,124 GRAIL Inc shares in Q1 2025, an estimated $948K.
  • Eagle Health Investments first reported a position in GRAIL Inc in Q2 2024 and held it in 3 quarters.
  • Eagle Health Investments's GRAIL Inc position peaked at $948K in Q4 2024.
  • 313 funds tracked by Wall St. Rank held GRAIL Inc as of Q1 2025.

Based on Eagle Health Investments's 13F filing for Q1 2025, filed 12 May 2025.